Kopp Investment Advisors’s Standard BioTools LAB Stock Holding History

Kopp Investment Advisors’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-80,288	Closed	-$1.94M	–	71
2015 Q2	$1.94M	Buy	80,288 +28,142	+54%	+$888K	0.87%	29
2015 Q1	$2.19M	Buy	52,146 +2,725	+6%	+$108K	0.97%	23
2014 Q4	$1.67M	Sell	49,421 -3,615	-7%	-$102K	0.8%	27
2014 Q3	$1.3M	Sell	53,036 -1,415	-3%	-$39.8K	0.64%	31
2014 Q2	$1.6M	Buy	54,451 +5,403	+11%	+$173K	0.74%	31
2014 Q1	$2.16M	Buy	+49,048	New	+$2.16M	0.91%	26
2013 Q4	–	Sell	-42,036	Closed	-$922K	–	71
2013 Q3	$922K	Sell	42,036 -5,820	-12%	-$114K	0.34%	57
2013 Q2	$836K	Buy	+47,856	New	+$840K	0.33%	65

Other funds holding LAB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SCM

Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Kopp Investment Advisors's LAB Position: Q3 2015 in Review

Kopp Investment Advisors sold out of Standard BioTools (LAB) in Q3 2015, closing a stake of 80,288 shares — an estimated $1.94M sold.

Kopp Investment Advisors first reported a position in LAB in Q2 2013 and held it in 8 quarters. The position peaked at $2.19M in Q1 2015. 109 funds tracked by Wall St. Rank hold LAB as of Q3 2015.

Kopp Investment Advisors reported no remaining Standard BioTools position as of Q3 2015 after selling out during the quarter.
Kopp Investment Advisors sold 80,288 Standard BioTools shares in Q3 2015, an estimated $1.94M.
Kopp Investment Advisors first reported a position in Standard BioTools in Q2 2013 and held it in 8 quarters.
Kopp Investment Advisors's Standard BioTools position peaked at $2.19M in Q1 2015.
109 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2015.

Based on Kopp Investment Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.